At Yazen, the medical team follows the principle of the lowest effective dose. This means that a patient's medication is never increased automatically simply because a standard dosing schedule recommends it. Together with the treating physician, the patient's progress and overall well-being are continuously evaluated.

If a patient experiences reduced food noise, feels satisfied after meals, and achieves steady weight loss at a lower dose, such as 1 mg or 1.7 mg of semaglutide, treatment will generally continue at that level. The goal is to identify the exact amount of medication the body needs to regulate appetite—no more and no less—while minimising the risk of side effects.

Data show that Yazen patients, on average, use 60% lower doses than those used in clinical studies.

Staying on the lowest effective dose offers several important benefits. From a medical perspective, it helps protect the body from unnecessary side effects, such as nausea, vomiting, and gastrointestinal discomfort, which may become more common as the dose increases. Regular physical activity and a balanced diet, combined with the medication, enhance its effectiveness and help reduce the risk of weight-related health conditions such as type 2 diabetes and high blood pressure.

In addition to the medical benefits, Yazen's approach may also reduce the overall cost of treatment. The monthly cost of Wegovy largely depends on how quickly the contents of the injection pen are used. By avoiding unnecessary dose increases and identifying the lowest effective maintenance dose, the same pen can last longer.

Wegovy is available as a pre-filled injection pen in the following dose strengths 0,25 mg, 0,5 mg, 1 mg, 1,7 mg och 2,4 mg.